Pages that link to "Q47835430"

The following pages link to Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. (Q47835430):

Displaying 68 items.

• Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis (Q24307293) ‎ (← links)
• Crosstalk between the heart and peripheral organs in heart failure (Q26766491) ‎ (← links)
• Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences (Q27021613) ‎ (← links)
• IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system (Q28585033) ‎ (← links)
• Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. (Q30514243) ‎ (← links)
• Intramyocardial fibroblast myocyte communication (Q33586605) ‎ (← links)
• Naturally Engineered Maturation of Cardiomyocytes (Q33639096) ‎ (← links)
• The extracellular matrix: at the center of it all. (Q33665667) ‎ (← links)
• Differential and conditional activation of PKC-isoforms dictates cardiac adaptation during physiological to pathological hypertrophy. (Q34035413) ‎ (← links)
• Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats (Q34066697) ‎ (← links)
• Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. (Q34588710) ‎ (← links)
• Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages (Q34639045) ‎ (← links)
• Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy. (Q35148756) ‎ (← links)
• Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II. (Q35152779) ‎ (← links)
• Vascular inflammation and endothelial dysfunction in experimental hypertension. (Q35207893) ‎ (← links)
• Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 (Q35571961) ‎ (← links)
• Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. (Q35710032) ‎ (← links)
• Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (Q35723859) ‎ (← links)
• The dynamics of fibroblast-myocyte-capillary interactions in the heart (Q35869237) ‎ (← links)
• The biochemical response of the heart to hypertension and exercise (Q35926480) ‎ (← links)
• Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. (Q36028045) ‎ (← links)
• Transforming growth factor-beta and Smad signalling in kidney diseases. (Q36037583) ‎ (← links)
• Anti-inflammatory properties of drugs acting on the renin-angiotensin system (Q36338078) ‎ (← links)
• Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart (Q36567314) ‎ (← links)
• Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways (Q36681664) ‎ (← links)
• Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems (Q36885445) ‎ (← links)
• Survival pathways in hypertrophy and heart failure: the gp130-STAT axis (Q36961847) ‎ (← links)
• Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. (Q37103166) ‎ (← links)
• Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection (Q37373747) ‎ (← links)
• Stromal cell biology--a way to understand the evolution of cardiovascular diseases (Q37727745) ‎ (← links)
• Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies (Q37741316) ‎ (← links)
• Statin therapy--Part II: Clinical considerations for cardiovascular disease (Q37765064) ‎ (← links)
• TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection (Q37773292) ‎ (← links)
• Angiotensin II and the vascular phenotype in hypertension (Q37859447) ‎ (← links)
• Angiotensin receptor modulation and cardiovascular remodeling. (Q37924418) ‎ (← links)
• Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation (Q37975121) ‎ (← links)
• Regulatory RNAs and paracrine networks in the heart. (Q38190443) ‎ (← links)
• Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction (Q38206408) ‎ (← links)
• Macromolecular Degradation Systems and Cardiovascular Aging (Q38833516) ‎ (← links)
• Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy. (Q39056785) ‎ (← links)
• The Cardiomyocyte as a Source of Cytokines in Cardiac Injury (Q41256651) ‎ (← links)
• Hsp90/Cdc37 assembly modulates TGFβ receptor-II to act as a profibrotic regulator of TGFβ signaling during cardiac hypertrophy. (Q41369890) ‎ (← links)
• Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis (Q41689291) ‎ (← links)
• Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation (Q43093520) ‎ (← links)
• Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence (Q43195079) ‎ (← links)
• Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms (Q44801176) ‎ (← links)
• Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats. (Q46841923) ‎ (← links)
• Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes (Q47232599) ‎ (← links)
• Extracellular Vesicles in Cardiovascular Theranostics. (Q49196893) ‎ (← links)
• Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy (Q50502374) ‎ (← links)
• Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta. (Q50789530) ‎ (← links)
• Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. (Q50927289) ‎ (← links)
• The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. (Q51796834) ‎ (← links)
• The TWEAK/Fn14 pathway is required for calcineurin inhibitor toxicity of the kidneys. (Q52738878) ‎ (← links)
• Attenuation of ischemic myocardial injury and dysfunction by cardiac fibroblast-derived factor(s). (Q54597152) ‎ (← links)
• Mechanical stresses induce paracrine β-2 microglobulin from cardiomyocytes to activate cardiac fibroblasts through epidermal growth factor receptor (Q59355460) ‎ (← links)
• Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy (Q60946704) ‎ (← links)
• Exosomes derived from cardiomyocytes promote cardiac fibrosis via myocyte-fibroblast cross-talk (Q60953235) ‎ (← links)
• Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy (Q81235828) ‎ (← links)
• The role of renin angiotensin system intervention in stage B heart failure (Q83616722) ‎ (← links)
• Cellular Communications in the Heart (Q88711547) ‎ (← links)
• The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human (Q90104612) ‎ (← links)
• Angiotensin II receptor blocker LCZ696 attenuates cardiac remodeling through the inhibition of the ERK signaling pathway in mice with pregnancy-associated cardiomyopathy (Q90931957) ‎ (← links)
• Cardiomyocyte targeted overexpression of IGF1 during detraining restores compromised cardiac condition via mTORC2 mediated switching of PKCδ to PKCα (Q91830099) ‎ (← links)
• A high-fat diet rich in corn oil induces cardiac fibrosis in rats by activating JAK2/STAT3 and subsequent activation of ANG II/TGF-1β/Smad3 pathway: The role of ROS and IL-6 trans-signaling (Q92333721) ‎ (← links)
• Interleukin-6 -634C>G polymorphism in hypertensive patients with and without left ventricular hypertrophy (Q95480571) ‎ (← links)
• Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines (Q96693310) ‎ (← links)
• Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis (Q100392904) ‎ (← links)